Skip to main content

Advanced treatment

TIL (tumour-infiltrating lymphocyte therapy)

Cell therapy that expands lymphocytes already present inside the patient's tumour, then returns them after preparatory treatment.

Ilustrasi alur terapi TIL dari pengambilan sel imun hingga infus kembali
Terapi selulerDraft, not yet medically reviewed

Not a diagnosis and not final medical advice. Must be reviewed by a doctor.

What is it?

In TIL, the patient's tumor tissue is used to obtain lymphocyte cells that recognize the tumor.

The cells are multiplied in the laboratory, then given back after preparatory therapy which is lymphodeplex.

This approach has been primarily studied in certain solid tumors, including melanoma and some cervical and lung cancers, and is still in the clinical research phase in many indications.

Lymphocytes taken from tumor tissue are multiplied in the laboratory and activated, then returned to the patient to attack tumor cells.
How TIL (tumour-infiltrating lymphocyte therapy)

How it works

Lymphocytes taken from tumor tissue are multiplied in the laboratory and activated, then returned to the patient to attack tumor cells.

Position in the treatment pathway: Generally only through clinical trials or special programs, usually after standard therapy no longer produces results.

Ilustrasi alur terapi TIL dari pengambilan sel imun hingga infus kembali

Which cancers is it usually discussed for?

Usually considered

  • Tumor tissue that can be accessed to obtain cells.
  • Organ conditions that allow preparatory therapy and monitoring.
  • Compliance with ongoing study criteria.

Usually not a candidate

  • There is not sufficient tumor tissue to obtain cells.
  • A medical condition that makes the procedure unacceptable.
  • There are no programs or studies available.

What is the process like?

  1. Preparation 1

    Removal of tumor tissue.

  2. Preparation 2

    Evaluation of organs and infection.

  3. Preparation 3

    Preparatory therapy planning.

  4. Monitoring

    Close monitoring after infusion.

All preparation

  • Removal of tumor tissue.
  • Evaluation of organs and infection.
  • Preparatory therapy planning.

All monitoring

  • Close monitoring after infusion.
  • Monitoring infection and blood cell recovery.
  • Evaluate response.

Risks and points to watch

Side-effect notes, not a complete list

This list covers categories commonly discussed. Individual risk is always assessed by the treating team.
  • Immune system related reactions may occur.
  • Infection and decreased blood cells during the recovery period.

Cost and access

Cost figures depend heavily on location, facility and payer. We do not show estimated figures on this page; what can be prepared first are the questions.

Providers and clinical trials

Access status not yet verified

Studies are filtered from the public registry. Site readiness and international patient acceptance still need confirmation before any travel is planned.

NO DATA

No studies in the latest registry data mention this treatment category in their description.

Questions for the doctor

  • Is there a TIL clinical trial that is appropriate for my condition?
  • What is the tissue collection process and how long does it take to prepare?
  • How is monitoring after infusion carried out?

Is TIL (tumour-infiltrating lymphocyte therapy) relevant for my case?

Ask for an initial review. We will explain which documents and markers need to be completed before discussion with a doctor.

  1. Upload reports

    Photos or PDFs of pathology, biomarkers, imaging and treatment history.

  2. Case structured

    Documents are turned into a structured case summary.

  3. Navigator review

    A human navigator checks completeness before anything is shared.

  4. Provider review

    With your consent, the case is discussed with providers for assessment and a written quote.

Is TIL (tumour-infiltrating lymphocyte therapy) relevant for my case?

Ask for an initial review. We will explain which documents and markers need to be completed before discussion with a doctor.

After submission, a human navigator reviews your request and contacts you through your chosen channel. The WhatsApp message already includes this page context, so you do not need to explain from the beginning.

Clinical data is not requested in the form and is not sent to analytics. Do not send medical reports through WhatsApp or email; use the secure upload page. We do not promise eligibility or any treatment outcome.

Next steps

These suggestions come from links between entries in TanyaKanker's database, not from a medical judgement. Each suggestion includes why it appears.

To check

What you can do

  • Upload medical reports

    Build a case summary in twelve steps

    Reason: Often the most useful next step after reading this page

  • Request a second opinion

    Review of the treatment plan

    Reason: Relevant when a treatment plan is being considered

  • Consult a navigator

    A request is recorded with this page context

    Reason: For asking the next step directly

Recently updated

Want to follow changes on this topic? Save the page or follow the topic so it is easy to find again. View saved items.

Prepare for your next consultation

Use the free six-question tool to prepare questions for your doctor.